Zai Lab (ZLAB) Current Leases (2019 - 2026)
Zai Lab (ZLAB) posted Current Leases of $6.0 million for Q1 2026, down 5.69% sequentially from $6.3 million in Q4 2025, and down 8.99% YoY from $6.6 million in Q1 2025.
Zai Lab (ZLAB) Current Leases (2019 - 2026) Analysis & Trends
Zai Lab has reported Current Leases for 8 years, with the latest figure at $6.0 million in Q1 2026.
- Quarterly Current Leases fell 8.99% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 8.99% YoY) and the FY2025 annual result came in at $6.3 million, down 21.17% from the prior year.
- Current Leases fell to $6.0 million in Q1 2026 per ZLAB's latest filing, from $6.3 million in the prior quarter.
- Over five years, Current Leases peaked at $8.0 million in Q4 2024 and troughed at $5.5 million in Q3 2025.
- A 5-year average of $6.8 million and a median of $6.9 million in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2025: Current Leases rose 21.3% in 2022, then decreased 26.34% in 2025.
- Over 5 years, Current Leases stood at $7.0 million in 2022, then gained by 0.77% to $7.1 million in 2023, then climbed by 13.29% to $8.0 million in 2024, then retreated by 21.17% to $6.3 million in 2025, then retreated by 5.69% to $6.0 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $6.0 million, $6.3 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.03 Mn |
| Mar 31, 2026 | 5.98 Mn |
| Dec 31, 2025 | 6.34 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 6.57 Mn |
| Dec 31, 2024 | 8.05 Mn |
| Sep 30, 2024 | 6.59 Mn |
| Jun 30, 2024 | 7.58 Mn |
| Mar 31, 2024 | 7.54 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 6.89 Mn |
| Jun 30, 2023 | 7.30 Mn |
| Mar 31, 2023 | 7.32 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 6.98 Mn |
| Jun 30, 2022 | 6.82 Mn |
| Mar 31, 2022 | 6.80 Mn |
| Dec 31, 2021 | 5.93 Mn |
| Sep 30, 2021 | 6.31 Mn |